|
USP21 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.62510000403893E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.52579999640668E-08 |
| Normal-vs-Stage2 |
1.597120E-03 |
| Normal-vs-Stage3 |
2.24490000033661E-07 |
| Normal-vs-Stage4 |
3.447300E-04 |
| Stage1-vs-Stage2 |
4.066200E-01 |
| Stage1-vs-Stage3 |
3.280000E-01 |
| Stage1-vs-Stage4 |
6.256000E-01 |
| Stage2-vs-Stage3 |
1.993780E-01 |
| Stage2-vs-Stage4 |
7.961200E-01 |
| Stage3-vs-Stage4 |
3.029000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14919999960605E-07 |
| Normal-vs-AfricanAmerican |
1.144150E-02 |
| Normal-vs-Asian |
7.953000E-04 |
| Caucasian-vs-AfricanAmerican |
3.922000E-01 |
| Caucasian-vs-Asian |
3.250600E-01 |
| AfricanAmerican-vs-Asian |
9.030400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.78160000000283E-05 |
| Normal-vs-Female |
4.21979995390842E-09 |
| Male-vs-Female |
1.608790E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.20519985289536E-10 |
| Normal-vs-Age(41-60Yrs) |
2.62910000004002E-06 |
| Normal-vs-Age(61-80Yrs) |
4.179000E-04 |
| Normal-vs-Age(81-100Yrs) |
8.756700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.381600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.603800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.269600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.156600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.763400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.823800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.836800E-03 |
| Classical-VS-Follicular |
2.947000E-01 |
| Classical-VS-Other |
8.970000E-01 |
| Classical-VS-Normal |
5.12840000022052E-07 |
| Tall-VS-Follicular |
1.339800E-01 |
| Tall-VS-Other |
3.577600E-01 |
| Tall-VS-Normal |
2.66260000048035E-07 |
| Follicular-VS-Other |
6.270200E-01 |
| Follicular-VS-Normal |
1.66882000000035E-05 |
| Other-VS-Normal |
1.256170E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.69289999998978E-06 |
| Normal-vs-N1 |
2.22139999950244E-07 |
| N0-vs-N1 |
8.652000E-02 |
|
|
